COA3
gene geneOn this page
Also known as HSPC009MITRAC12COX25hCOA3
Summary
COA3 (cytochrome c oxidase assembly factor 3, HGNC:24990) is a protein-coding gene on chromosome 17q21.2, encoding Cytochrome c oxidase assembly factor 3 homolog, mitochondrial (Q9Y2R0). Core component of the MITRAC (mitochondrial translation regulation assembly intermediate of cytochrome c oxidase complex) complex, that regulates cytochrome c oxidase assembly. It is a selective cancer dependency (DepMap: 17.7% of cell lines).
This gene encodes a member of the cytochrome c oxidase assembly factor family. Studies of a related gene in fly suggest that the encoded protein is localized to mitochondria and is essential for cytochrome c oxidase function.
Source: NCBI Gene 28958 — RefSeq curated summary.
At a glance
- Gene–disease (curated): cytochrome-c oxidase deficiency disease (Supportive, GenCC) — +2 more curated relationships
- Clinical variants (ClinVar): 46 total
- Phenotypes (HPO): 11
- Cancer dependency (DepMap): dependent in 17.7% of screened cell lines
- MANE Select transcript:
NM_001040431
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:24990 |
| Approved symbol | COA3 |
| Name | cytochrome c oxidase assembly factor 3 |
| Location | 17q21.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | HSPC009, MITRAC12, COX25, hCOA3 |
| Ensembl gene | ENSG00000183978 |
| Ensembl biotype | protein_coding |
| OMIM | 614775 |
| Entrez | 28958 |
Gene structure
Transcript identifiers
Ensembl transcripts: 2 — 1 protein_coding, 1 nonsense_mediated_decay
ENST00000328434, ENST00000586680
RefSeq mRNA: 1 — MANE Select: NM_001040431
NM_001040431
CCDS: CCDS32660
Canonical transcript exons
ENST00000328434 — 2 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001318691 | 42797625 | 42798167 |
| ENSE00002974911 | 42798468 | 42798704 |
Expression profiles
Bgee: expression breadth ubiquitous, 285 present calls, max score 98.95.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 31.2827 / max 169.3150, expressed in 1809 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 166188 | 31.2827 | 1809 |
Top tissues by expression
288 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| mucosa of transverse colon | UBERON:0004991 | 98.95 | gold quality |
| corpus epididymis | UBERON:0004359 | 98.72 | gold quality |
| renal medulla | UBERON:0000362 | 98.26 | gold quality |
| body of pancreas | UBERON:0001150 | 98.26 | gold quality |
| metanephros cortex | UBERON:0010533 | 98.07 | gold quality |
| mucosa of sigmoid colon | UBERON:0004993 | 97.81 | gold quality |
| colonic mucosa | UBERON:0000317 | 97.80 | gold quality |
| oral cavity | UBERON:0000167 | 97.75 | gold quality |
| duodenum | UBERON:0002114 | 97.55 | gold quality |
| body of stomach | UBERON:0001161 | 97.53 | gold quality |
| gingiva | UBERON:0001828 | 97.52 | gold quality |
| gingival epithelium | UBERON:0001949 | 97.45 | gold quality |
| cervix squamous epithelium | UBERON:0006922 | 97.42 | gold quality |
| adult organism | UBERON:0007023 | 97.37 | gold quality |
| bronchial epithelial cell | CL:0002328 | 97.36 | gold quality |
| transverse colon | UBERON:0001157 | 97.35 | gold quality |
| prefrontal cortex | UBERON:0000451 | 97.31 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 97.29 | gold quality |
| adult mammalian kidney | UBERON:0000082 | 97.28 | gold quality |
| cingulate cortex | UBERON:0003027 | 97.26 | gold quality |
| rectum | UBERON:0001052 | 97.23 | gold quality |
| right frontal lobe | UBERON:0002810 | 97.23 | gold quality |
| tongue squamous epithelium | UBERON:0006919 | 97.23 | gold quality |
| epithelium of bronchus | UBERON:0002031 | 97.21 | gold quality |
| esophagus mucosa | UBERON:0002469 | 97.15 | gold quality |
| amygdala | UBERON:0001876 | 97.14 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 97.14 | gold quality |
| cortex of kidney | UBERON:0001225 | 97.11 | gold quality |
| nephron tubule | UBERON:0001231 | 97.09 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 97.09 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 2.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-HCAD-10 | yes | 27.01 |
| E-ANND-3 | no | 0.00 |
Regulation
Is transcription factor: no
Functional genomics
DepMap (CRISPR cell-line fitness): dependent in 17.7% of screened cell lines.
Literature-anchored findings (GeneRIF, showing 6)
- Human ortholog of fungal COA3 (Cytochrome oxidase assembly) (PMID:22356826)
- Study comprehensively identified mammalian cytochrome c oxidase assembly factors. These analyses led to the discoveryof MITRAC12, which defines the MITRAC (mitochondrial translation regulation assembly intermediate of cytochrome c oxidase)complexes. (PMID:23260140)
- hCOA3 stabilizes COX1 co-translationally and promotes its assembly with COX partner subunits. (PMID:23362268)
- COX14 was undetectable in COA3 subject fibroblasts, and that COA3 was undetectable in fibroblasts from a COX14 subject, demonstrating the interdependence of these two COX assembly factors (PMID:25604084)
- Data show that mitochondrial protein ccdc56/MITRAC12/COA3 positively regulates mitochondrial fission by recruiting the fission factor Drp1. (PMID:26358295)
- Data suggest that COX assembly factor 3 (hCOA3) is a disordered protein and that the flexibility of hCOA3 is crucial for its interaction with other proteins to favor mitochondrial protein translocation and assembly of proteins involved in the respiratory chain. (PMID:27791355)
Cross-species orthologs
4 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | coa3a | ENSDARG00000100585 |
| mus_musculus | Coa3 | ENSMUSG00000017188 |
| rattus_norvegicus | Coa3 | ENSRNOG00000020487 |
| caenorhabditis_elegans | WBGENE00018046 |
Protein
Protein identifiers
Cytochrome c oxidase assembly factor 3 homolog, mitochondrial — Q9Y2R0 (reviewed: Q9Y2R0)
Alternative names: Coiled-coil domain-containing protein 56, Mitochondrial translation regulation assembly intermediate of cytochrome c oxidase protein of 12 kDa
All UniProt accessions (2): Q9Y2R0, K7EPV0
UniProt curated annotations — full annotation on UniProt →
Function. Core component of the MITRAC (mitochondrial translation regulation assembly intermediate of cytochrome c oxidase complex) complex, that regulates cytochrome c oxidase assembly. MITRAC complexes regulate both translation of mitochondrial encoded components and assembly of nuclear-encoded components imported in mitochondrion. Required for efficient translation of MT-CO1 and mitochondrial respiratory chain complex IV assembly.
Subunit / interactions. Along with COX14, core component of the MITRAC (mitochondrial translation regulation assembly intermediate of cytochrome c oxidase complex) complex. Interacts with MT-CO1/COX1, SMIM20, SURF1 and TIMM21.
Subcellular location. Mitochondrion inner membrane.
Disease relevance. Mitochondrial complex IV deficiency, nuclear type 14 (MC4DN14) [MIM:619058] An autosomal recessive mitochondrial disorder with onset in early childhood. MC4DN14 is characterized by developmental delay, cognitive impairment, motor delay, abnormal gait, sensorimotor demyelinating polyneuropathy, exercise intolerance, obesity, and short stature. Serum lactate levels are marginally increased. Patient tissues show decreased levels and activity of mitochondrial respiratory complex IV. The disease may be caused by variants affecting the gene represented in this entry.
Similarity. Belongs to the COA3 family.
RefSeq proteins (1): NP_001035521* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR018628 | Coa3_CC | Domain |
| IPR041752 | Coa3 | Family |
Pfam: PF09813
UniProt features (9 total): topological domain 2, initiator methionine 1, chain 1, transmembrane region 1, region of interest 1, coiled-coil region 1, modified residue 1, sequence variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9Y2R0-F1 | 77.32 | 0.25 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (1): 2
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-9864848 | Complex IV assembly |
MSigDB gene sets: 181 (showing top):
GOBP_RESPIRATORY_CHAIN_COMPLEX_IV_ASSEMBLY, STARK_PREFRONTAL_CORTEX_22Q11_DELETION_DN, GOBP_MITOCHONDRIAL_RESPIRATORY_CHAIN_COMPLEX_ASSEMBLY, GOBP_MITOCHONDRIAL_TRANSLATION, RACCACAR_AML_Q6, CAGCTG_AP4_Q5, GOBP_CYTOCHROME_COMPLEX_ASSEMBLY, GOBP_TRANSLATION, GOBP_POST_TRANSCRIPTIONAL_REGULATION_OF_GENE_EXPRESSION, GOBP_PROTEIN_MATURATION, RGTTAMWNATT_HNF1_01, GOCC_MITOCHONDRIAL_ENVELOPE, YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_13, TGANTCA_AP1_C, GOBP_PROTEIN_FOLDING
GO Biological Process (2): mitochondrial respiratory chain complex IV assembly (GO:0033617), positive regulation of mitochondrial translation (GO:0070131)
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (4): mitochondrion (GO:0005739), mitochondrial inner membrane (GO:0005743), membrane (GO:0016020), mitochondrial membrane (GO:0031966)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| Respiratory electron transport | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| mitochondrion | 2 |
| respiratory chain complex IV assembly | 1 |
| mitochondrial respiratory chain complex assembly | 1 |
| mitochondrial translation | 1 |
| positive regulation of translation | 1 |
| regulation of mitochondrial translation | 1 |
| binding | 1 |
| cytoplasm | 1 |
| intracellular membrane-bounded organelle | 1 |
| organelle inner membrane | 1 |
| mitochondrial membrane | 1 |
| cellular anatomical structure | 1 |
| mitochondrial envelope | 1 |
| organelle membrane | 1 |
Protein interactions and networks
STRING
1104 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| COA3 | COX14 | Q96I36 | 984 |
| COA3 | SURF1 | Q15526 | 877 |
| COA3 | COA6 | Q5JTJ3 | 807 |
| COA3 | COX15 | Q7KZN9 | 797 |
| COA3 | COA1 | Q9GZY4 | 774 |
| COA3 | COX16 | Q9P0S2 | 746 |
| COA3 | TACO1 | Q9BSH4 | 722 |
| COA3 | MSS51 | Q4VC12 | 716 |
| COA3 | SMIM20 | Q8N5G0 | 703 |
| COA3 | COX5A | P20674 | 695 |
| COA3 | COX10 | Q12887 | 683 |
| COA3 | COX20 | Q5RI15 | 642 |
| COA3 | CMC1 | Q7Z7K0 | 618 |
| COA3 | COA5 | Q86WW8 | 612 |
| COA3 | COX5B | P10606 | 604 |
IntAct
47 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| COA3 | MT-CO1 | psi-mi:“MI:0914”(association) | 0.610 |
| MT-CO1 | COA3 | psi-mi:“MI:0915”(physical association) | 0.610 |
| COA3 | MT-CO1 | psi-mi:“MI:0915”(physical association) | 0.610 |
| SURF1 | COA3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TIMM21 | TIMM23 | psi-mi:“MI:0914”(association) | 0.500 |
| COA3 | ATAD3A | psi-mi:“MI:0915”(physical association) | 0.460 |
| COA3 | ATAD3A | psi-mi:“MI:0403”(colocalization) | 0.460 |
| Smc3 | PDS5B | psi-mi:“MI:0914”(association) | 0.350 |
| K8.1 | EXOC5 | psi-mi:“MI:0914”(association) | 0.350 |
| MAD2L2 | psi-mi:“MI:0914”(association) | 0.350 | |
| DND1 | RPSA2 | psi-mi:“MI:0914”(association) | 0.350 |
| NMES1 | NDUFS8 | psi-mi:“MI:0914”(association) | 0.350 |
| COQ9 | NDUFS8 | psi-mi:“MI:0914”(association) | 0.350 |
| NDUFA4 | NUDT19 | psi-mi:“MI:0914”(association) | 0.350 |
| CHCHD10 | RNASEH1 | psi-mi:“MI:0914”(association) | 0.350 |
| NDUFA4 | NDUFS8 | psi-mi:“MI:0914”(association) | 0.350 |
| NMES1 | COX7A2L | psi-mi:“MI:0914”(association) | 0.350 |
| COQ9 | ACOT7 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (111): COA3 (Affinity Capture-RNA), COA3 (Affinity Capture-MS), COA3 (Affinity Capture-MS), COA3 (Affinity Capture-MS), COA3 (Affinity Capture-MS), COA3 (Affinity Capture-MS), COX1 (Affinity Capture-Western), COX2 (Affinity Capture-Western), COX3 (Affinity Capture-Western), COX4I1 (Affinity Capture-Western), COX4I2 (Affinity Capture-Western), COX5A (Affinity Capture-Western), NDUFA9 (Affinity Capture-Western), NDUFV1 (Affinity Capture-Western), TUFM (Affinity Capture-Western)
ESM2 similar proteins: A0A1N7SYS3, A1C8Z3, A1CMM2, A1XQS1, A3LQD9, A5DM93, A5DTG8, A6R620, A6ZUI6, A7TFK6, B3DFP2, B3LI56, C5DE77, C5E368, C6Y4C1, C7GT24, C8Z970, P0CM84, P0CM85, P37267, P38958, P47081, Q02771, Q0UIR3, Q1DME3, Q2PIY2, Q3T0E3, Q4I8P5, Q52ZA1, Q59QC6, Q5ACH7, Q5AXJ9, Q5R7J0, Q6BI17, Q6BY05, Q6C5S0, Q6CCF6, Q6CHT7, Q6CJX5, Q6CK73
Diamond homologs: A8KB87, P0DKM0, Q3T0E3, Q5R7J0, Q9D2R6, Q9Y2R0
SIGNOR signaling
1 interactions.
| A | Effect | B | Mechanism |
|---|---|---|---|
| COA3 | “form complex” | “MITRAC complex” | binding |
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 40 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
Reactome pathways:
| Pathway | Partners | Fold | FDR |
|---|---|---|---|
| Complex IV assembly | 10 | 81.6× | 7e-16 |
| Cytoprotection by HMOX1 | 5 | 32.9× | 7e-06 |
| Respiratory electron transport | 9 | 30.6× | 2e-10 |
| TP53 Regulates Metabolic Genes | 5 | 23.2× | 3e-05 |
GO biological processes:
| GO term | Partners | Fold | FDR |
|---|---|---|---|
| mitochondrial electron transport, cytochrome c to oxygen | 5 | 112.7× | 1e-07 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
46 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 33 |
| Likely benign | 9 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
975 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 17:42796319:CCTG:C | donor_loss | 1.0000 |
| 17:42796321:TGGTG:T | donor_loss | 1.0000 |
| 17:42796323:G:GC | donor_loss | 1.0000 |
| 17:42796324:T:G | donor_loss | 1.0000 |
| 17:42796546:G:GT | donor_gain | 1.0000 |
| 17:42796574:GGATG:G | donor_gain | 1.0000 |
| 17:42796575:G:GT | donor_gain | 1.0000 |
| 17:42796684:A:AG | acceptor_gain | 1.0000 |
| 17:42796685:G:GG | acceptor_gain | 1.0000 |
| 17:42795679:C:G | donor_gain | 0.9900 |
| 17:42795804:G:GT | donor_gain | 0.9900 |
| 17:42795804:G:T | donor_gain | 0.9900 |
| 17:42796031:GAA:G | donor_gain | 0.9900 |
| 17:42796034:G:GG | donor_gain | 0.9900 |
| 17:42796323:G:GG | donor_gain | 0.9900 |
| 17:42796325:GA:G | donor_loss | 0.9900 |
| 17:42796564:G:GT | donor_gain | 0.9900 |
| 17:42796564:G:T | donor_gain | 0.9900 |
| 17:42796576:A:T | donor_gain | 0.9900 |
| 17:42796684:AGT:A | acceptor_gain | 0.9900 |
| 17:42796685:GT:G | acceptor_gain | 0.9900 |
| 17:42796685:GTG:G | acceptor_gain | 0.9900 |
| 17:42796685:GTGA:G | acceptor_gain | 0.9900 |
| 17:42798497:AGG:A | donor_gain | 0.9900 |
| 17:42795678:GC:G | donor_gain | 0.9800 |
| 17:42795832:C:G | donor_gain | 0.9800 |
| 17:42796117:CCTCA:C | acceptor_loss | 0.9800 |
| 17:42796119:TCAG:T | acceptor_loss | 0.9800 |
| 17:42796120:CA:C | acceptor_loss | 0.9800 |
| 17:42796121:A:AG | acceptor_gain | 0.9800 |
AlphaMissense
652 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 17:42798488:C:T | G65E | 0.985 |
| 17:42798164:C:T | G73D | 0.981 |
| 17:42798485:G:T | A66D | 0.977 |
| 17:42798165:C:G | G73R | 0.975 |
| 17:42798489:C:G | G65R | 0.972 |
| 17:42798489:C:T | G65R | 0.972 |
| 17:42798500:C:T | G61D | 0.972 |
| 17:42798495:C:G | G63R | 0.969 |
| 17:42798130:G:C | F84L | 0.968 |
| 17:42798130:G:T | F84L | 0.968 |
| 17:42798132:A:G | F84L | 0.968 |
| 17:42798501:C:G | G61R | 0.963 |
| 17:42798473:G:T | A70D | 0.961 |
| 17:42798494:C:T | G63D | 0.956 |
| 17:42798131:A:G | F84S | 0.955 |
| 17:42798479:A:T | V68E | 0.947 |
| 17:42798482:A:C | L67R | 0.946 |
| 17:42798131:A:C | F84C | 0.940 |
| 17:42798139:C:A | Q81H | 0.931 |
| 17:42798139:C:G | Q81H | 0.931 |
| 17:42798491:A:T | I64N | 0.931 |
| 17:42798511:G:C | N57K | 0.931 |
| 17:42798511:G:T | N57K | 0.931 |
| 17:42798150:A:G | S78P | 0.920 |
| 17:42798497:A:C | L62R | 0.920 |
| 17:42798158:G:A | T75I | 0.919 |
| 17:42798137:T:A | E82V | 0.917 |
| 17:42798144:A:G | S80P | 0.916 |
| 17:42798162:A:C | Y74D | 0.912 |
| 17:42798470:A:T | I71N | 0.906 |
dbSNP variants (sampled 300 via entrez): RS1000388767 (17:42800324 T>C), RS1000665020 (17:42799680 A>T), RS1001127334 (17:42798636 C>G,T), RS1002953265 (17:42797281 C>A,T), RS1003290125 (17:42797648 T>C), RS1006232860 (17:42797533 T>A), RS1006870933 (17:42800541 T>C), RS1010897209 (17:42800356 G>A), RS1012987656 (17:42798229 C>A), RS1013013292 (17:42797716 C>T), RS1013041045 (17:42798593 A>C), RS1013044914 (17:42797303 A>G), RS1013891505 (17:42800287 C>T), RS1014185046 (17:42800611 G>A,T), RS1014963918 (17:42797919 T>C)
Disease associations
OMIM: gene MIM:614775 | disease phenotypes: MIM:619058, MIM:220110
GenCC curated gene-disease
| Disease | Classification | Inheritance |
|---|---|---|
| cytochrome-c oxidase deficiency disease | Supportive | Autosomal recessive |
| mitochondrial complex IV deficiency, nuclear type 14 | Limited | Unknown |
ClinGen Gene-Disease Validity (1)
Expert-panel classifications — Definitive > Strong > Moderate > Limited > Disputed > Refuted.
| Disease | Classification | Inheritance |
|---|---|---|
| mitochondrial disease | Limited | AR |
Mondo (3): mitochondrial complex IV deficiency, nuclear type 14 (MONDO:0033649), mitochondrial complex IV deficiency, nuclear type 1 (MONDO:0700250), (MONDO:0009068)
Orphanet (0):
HPO phenotypes
11 total (11 of 11 shown, HPO-id order):
| HPO | Term |
|---|---|
| HP:0000007 | Autosomal recessive inheritance |
| HP:0000286 | Epicanthus |
| HP:0000490 | Deeply set eye |
| HP:0001263 | Global developmental delay |
| HP:0001513 | Obesity |
| HP:0003546 | Exercise intolerance |
| HP:0003688 | Cytochrome C oxidase-negative muscle fibers |
| HP:0004322 | Short stature |
| HP:0007141 | Sensorimotor neuropathy |
| HP:0008347 | Decreased activity of mitochondrial complex IV |
| HP:0100543 | Cognitive impairment |
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
32 total (human), top 30 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| bisphenol A | affects expression, increases expression, decreases reaction, increases abundance | 2 |
| sodium arsenite | decreases expression, increases expression | 2 |
| cobaltous chloride | decreases expression | 2 |
| Acetaminophen | decreases expression | 2 |
| Valproic Acid | affects cotreatment, increases expression, affects expression | 2 |
| aristolochic acid I | decreases expression | 1 |
| GSK-J4 | decreases expression | 1 |
| bisphenol F | affects cotreatment, increases expression | 1 |
| ginger extract | decreases reaction, increases abundance, increases expression | 1 |
| tris(1,3-dichloro-2-propyl)phosphate | decreases expression | 1 |
| potassium chromate(VI) | affects cotreatment, decreases expression | 1 |
| epigallocatechin gallate | affects cotreatment, decreases expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| corosolic acid | decreases expression | 1 |
| ICG 001 | increases expression | 1 |
| Benzo(a)pyrene | decreases expression | 1 |
| Cadmium | increases abundance, increases expression | 1 |
| Dexamethasone | affects cotreatment, increases expression | 1 |
| Dimethyl Sulfoxide | increases expression | 1 |
| Doxorubicin | increases expression | 1 |
| Hydralazine | affects cotreatment, increases expression | 1 |
| Indomethacin | affects cotreatment, increases expression | 1 |
| Ivermectin | decreases expression | 1 |
| Oils, Volatile | decreases reaction, increases abundance, increases expression | 1 |
| Thiram | decreases expression | 1 |
| Urethane | decreases expression | 1 |
| 1-Methyl-3-isobutylxanthine | affects cotreatment, increases expression | 1 |
| Cyclosporine | decreases expression | 1 |
| Cadmium Chloride | increases abundance, increases expression | 1 |
| Okadaic Acid | decreases expression | 1 |
Cellosaurus cell lines
1 cell lines: 1 transformed cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_B2UR | Abcam HEK293T COA3 KO | Transformed cell line | Female |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Associated diseases: mitochondrial complex IV deficiency, nuclear type 14, mitochondrial disease
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): mitochondrial complex IV deficiency, nuclear type 1, mitochondrial complex IV deficiency, nuclear type 14